Nuclear magnetic resonance evidence for retention of a lamellar membrane phase with curvature in the presence of large quantities of the HIV fusion peptide

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 2, 2010, Pages 194-201

  Gabrys, Charles M ^a   Yang, Rong ^a   Wasniewski, Christopher M ^a   Yang, Jun ^a   Canlas, Christian G ^a   Qiang, Wei ^a   Sun, Yan ^a   Weliky, David P ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Curvature; Fusion; HIV; Membrane; NMR; Peptide

Indexed keywords

CHOLESTEROL; HUMAN IMMUNODEFICIENCY VIRUS FUSION PEPTIDE; LIPID; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN;

ARTICLE; DEUTERON NUCLEAR MAGNETIC RESONANCE; MEMBRANE BIOLOGY; MEMBRANE FUSION; MEMBRANE TRANSPORT; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE;

CHOLESTEROL; HIV; HIV ENVELOPE PROTEIN GP41; LIPID BILAYERS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES; PHOSPHATIDYLETHANOLAMINES;

ORTHOMYXOVIRIDAE;

EID: 74249088667     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.07.007     Document Type: Article

References (49)

1. White J.M., Delos S.E., Brecher M., and Schornberg K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 43 (2008) 189-219
2. Durell S.R., Martin I., Ruysschaert J.M., Shai Y., and Blumenthal R. What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion. Mol. Membr. Biol. 14 (1997) 97-112
3. Qiang W., Bodner M.L., and Weliky D.P. Solid-state NMR spectroscopy of human immunodeficiency virus fusion peptides associated with host-cell-like membranes: 2D correlation spectra and distance measurements support a fully extended conformation and models for specific antiparallel strand registries. J. Am. Chem. Soc. 130 (2008) 5459-5471
4. Qiang W., Yang J., and Weliky D.P. Solid-state nuclear magnetic resonance measurements of HIV fusion peptide to lipid distances reveal the intimate contact of beta strand peptide with membranes and the proximity of the Ala-14-Gly-16 region with lipid headgroups. Biochemistry 46 (2007) 4997-5008
5. Qiang W., and Weliky D.P. HIV fusion peptide and its cross-linked oligomers: efficient syntheses, significance of the trimer in fusion activity, correlation of β strand conformation with membrane cholesterol, and proximity to lipid headgroups. Biochemistry 48 (2009) 289-301
6. Epand R.F., Martin I., Ruysschaert J.-M., and Epand R.M. Membrane orientation of the SIV fusion peptide determines its effect on bilayer stability and ability to promote membrane fusion. Biochem. Biophys. Res. Comm. 205 (1994) 1938-1943
7. 31P NMR. Biochem. Biophys. Res. Commun. 250 (1998) 12-14
8. Pereira F.B., Valpuesta J.M., Basanez G., Goni F.M., and Nieva J.L. Interbilayer lipid mixing induced by the human immunodeficiency virus type-1 fusion peptide on large unilamellar vesicles: the nature of the nonlamellar intermediates. Chem. Phys. Lipids 103 (1999) 11-20
9. Peisajovich S.G., Epand R.F., Pritsker M., Shai Y., and Epand R.M. The polar region consecutive to the HIV fusion peptide participates in membrane fusion. Biochemistry 39 (2000) 1826-1833
10. Epand R.M. Lipid polymorphism and protein-lipid interactions. Biochim. Biophys. Acta 1376 (1998) 353-368
11. Siegel D.P. The energetics of intermediates in membrane fusion: comparison of stalk and inverted micellar intermediate mechanisms. Biophys. J. 65 (1993) 2124-2140
12. Siegel D.P., and Epand R.M. The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: implications for membrane fusion mechanisms. Biophys. J. 73 (1997) 3089-3111
13. Epand R.M. Fusion peptides and the mechanism of viral fusion. Biochim. Biophys. Acta 1614 (2003) 116-121
14. Bloom M., Evans E., and Mouritsen O.G. Physical properties of the fluid lipid-bilayer component of cell membranes: a perspective. Quart. Rev. Biophys. 24 (1991) 293-397
15. Seelig J. Deuterium magnetic resonance: theory and application to lipid membranes. Quart. Rev. Biophys. 10 (1977) 353-418
16. Seelig J., and Seelig A. Lipid conformation in model membranes. Quart. Rev. Biophys. 13 (1980) 19-64
17. Bloom M., and Sternin E. Transverse nuclear spin relaxation in phospholipid bilayer membranes. Biochemistry 26 (1987) 2101-2105
18. Chang C.D., Waki M., Ahmad M., Meienhofer J., Lundell E.O., and Haug J.D. Preparation and properties of N-α-9-fluorenylmethyloxycarbonylamino acids bearing tert-butyl side chain protection. Int. J. Pept. Protein Res. 15 (1980) 59-66
19. Lapatsanis L., Milias G., Froussios K., and Kolovos M. Synthesis of N-2,2,2-(trichloroethoxycarbonyl)-l-amino acids and N-(9-fluorenylmethoxycarbonyl)-l-amino acids involving succinimidoxy anion as a leaving group in amino-acid protection. Synthesis 8 (1983) 671-673
20. Freed E.O., Delwart E.L., Buchschacher Jr. G.L., and Panganiban A.T. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 70-74
21. Pereira F.B., Goni F.M., and Nieva J.L. Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution. FEBS Lett. 362 (1995) 243-246
22. Wasniewski C.M., Parkanzky P.D., Bodner M.L., and Weliky D.P. Solid-state nuclear magnetic resonance studies of HIV and influenza fusion peptide orientations in membrane bilayers using stacked glass plate samples. Chem. Phys. Lipids 132 (2004) 89-100
23. Dempsey C.E. The actions of melittin on membranes. Biochim. Biophys. Acta 1031 (1990) 143-161
24. 13C NMR spectroscopy. Biophys. J. 78 (2000) 2405-2417
25. Aloia R.C., Tian H., and Jensen F.C. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 5181-5185
26. Brugger B., Glass B., Haberkant P., Leibrecht I., Wieland F.T., and Krasslich H.G. The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 2641-2646
27. Struck D.K., Hoekstra D., and Pagano R.E. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20 (1981) 4093-4099
28. Yang J., Gabrys C.M., and Weliky D.P. Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane-bound HIV-1 fusion peptide. Biochemistry 40 (2001) 8126-8137
29. Pereira F.B., Goni F.M., Muga A., and Nieva J.L. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects. Biophys. J. 73 (1997) 1977-1986
30. Gullion T., and Schaefer J. Rotational-echo double-resonance NMR. J. Magn. Reson. 81 (1989) 196-200
31. Bennett A.E., Rienstra C.M., Auger M., Lakshmi K.V., and Griffin R.G. Heteronuclear decoupling in rotating solids. J. Chem. Phys. 103 (1995) 6951-6958
32. Gullion T., Baker D.B., and Conradi M.S. New, compensated Carr-Purcell sequences. J. Magn. Reson. 89 (1990) 479-484
33. Gullion T., and Schaefer J. Elimination of resonance offset effects in rotational-echo, double-resonance NMR. J. Magn. Reson. 92 (1991) 439-442
34. Morcombe C.R., and Zilm K.W. Chemical shift referencing in MAS solid state NMR. J. Magn. Reson. 162 (2003) 479-486
35. Hoult D.I., and Richards R.E. Critical factors in the design of sensitive high resolution nuclear magnetic resonance spectrometers. Proc. R. Soc. Lond., Ser. A 344 (1975) 311-340
36. Yang R., Prorok M., Castellino F.J., and Weliky D.P. A trimeric HIV-1 fusion peptide construct which does not self-associate in aqueous solution and which has 15-fold higher membrane fusion rate. J. Am. Chem. Soc. 126 (2004) 14722-14723
37. Yang J., Parkanzky P.D., Bodner M.L., Duskin C.G., and Weliky D.P. Application of REDOR subtraction for filtered MAS observation of labeled backbone carbons of membrane-bound fusion peptides. J. Magn. Reson. 159 (2002) 101-110
38. Yang J., Prorok M., Castellino F.J., and Weliky D.P. Oligomeric beta structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers. Biophys. J. 87 (2004) 1951-1963
39. Zhang H.Y., Neal S., and Wishart D.S. RefDB: a database of uniformly referenced protein chemical shifts. J. Biomol. NMR 25 (2003) 173-195
40. 31P determinations of phospholipid polymorphic phase behaviour. Chem. Phys. Lipids 40 (1986) 47-56
41. Rilfors L., Eriksson P.-O., Arvidson G., and Lindblom G. Relationship between three-dimensional arrays of "lipidic particles" and bicontinuous cubic lipid phases. Biochemistry 25 (1986) 7702-7711
42. Shyamsunder E., Gruner S.M., Tate M.W., Turner D.C., So P.T.C., and Tilcock C.P.S. Observation of inverted cubic phase in hydrated dioleoylphosphatidylethanolamine membranes. Biochemistry 27 (1988) 2332-2336
43. 2H and divalent cations on the motion in the phosphate region of the polar headgroup. Biochim. Biophys. Acta 436 (1976) 523-540
44. Sackett K., Nethercott M.J., Shai Y., and Weliky D.P. Hairpin folding of HIV gp41 abrogates lipid mixing function at physiologic pH and inhibits lipid mixing by exposed gp41 constructs. Biochemistry 48 (2009) 2714-2722
45. Curtain C., Separovic F., Nielsen K., Craik D., Zhong Y., and Kirkpatrick A. The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids. Eur. Biophys. J. 28 (1999) 427-436
46. Yang J., Parkanzky P.D., Khunte B.A., Canlas C.G., Yang R., Gabrys C.M., and Weliky D.P. Solid state NMR measurements of conformation and conformational distributions in the membrane-bound HIV-1 fusion peptide. J. Mol. Graph. Model. 19 (2001) 129-135
47. Agrawal P., Kiihne S., Hollander J., Hulsbergen F., Hofmann M., Langosch D., and de Groot H. Solid state NMR investigation of the interaction between biomimetic lipid bilayers and de novo designed fusogenic peptides. Chembiochem 8 (2007) 493-496
48. Tristram-Nagle S., and Nagle J.F. HIV-1 fusion peptide decreases bending energy and promotes curved fusion intermediates. Biophys. J. 93 (2007) 2048-2055
49. Colotto A., and Epand R.M. Structural study of the relationship between the rate of membrane fusion and the ability of the fusion peptide of influenza virus to perturb bilayers. Biochemistry 36 (1997) 7644-7651